References
Alpha-1 Foundation. 2003. Alpha-1 Foundation Homepage. Available: http://www.alphaone.org [accessed 3 October 2003].
Bazex J, Bayle P, Albes B. 2002. Alpha-1-antitrypsin deficiency. Cutaneous aspects. Bull Acad Natl Med 186:1479-1487.
Blanco I, Fernandez E, Bustillo E. 2001. Alpha-1-antitrypsin Pi phenotypes S and Z in Europe: an analysis of the published surveys. Clin Genet 60:31-41.
Blank CA, Brantly M. 1994. Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency. Ann Allergy 72:105-120.
Brantly M. 1996. Alpha 1-antitrypsin genotypes and phenotypes. In: Alpha 1-Antitrypsin Deficiency: Biology, Pathogenesis, Clinical Manifestations, Therapy (Crystal RG, ed). Lung Biology in Health and Disease, Vol 88. New York:Marcel Dekker Inc., 45-59.
Brantly ML, Paul LD, Miller BH, Falk RT, Wu M, Crystal RG. 1988. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 138:327-336.
Buist AS, Burrows B, Eriksson S, Mittman C, Wu M. 1983. The natural history of air-flow obstruction in PiZ emphysema. Report of an NHIBI workshop. Am Rev Respir Dis 127:S43-45.
Byth BC, Billingsley GD, Cox DW. 1994. Physical and genetic mapping of the serpin gene cluster at 14q32.1: allelic association and a unique haplotype associated with alpha 1-antitrypsin deficiency. Am J Hum Genet 55:126-133.
Carlson J, Eriksson S. 1985. Chronic 'cryptogenic' liver disease and malignant hepatoma in intermediate alpha 1-antitrypsin deficiency identified by a PiZ-specific monoclonal antibody. Scand J Gastroenterol 20:835-842.
Carrell RW, Lomas DA. 2002. Alpha1-antitrypsin deficiency--a model for conformational diseases. N Engl J Med 346:45-53.
Colp C, Pappas J, Moran D, Lieberman J. 1993. Variants of alpha-1-antitrypsin in Puerto Rican children with asthma. Chest 103:812-815.
Cox DW, Billingsley GD, Mansfield T. 1987. DNA restriction-site polymorphisms associated with the alpha 1-antitrypsin gene. Am J Hum Genet 41:891-906.
Cox DW, Woo SL, Mansfield T. 1985. DNA restriction fragments associated with alpha 1-antitrypsin indicate a single origin for deficiency allele PiZ. Nature 316:79-81.
Crystal RG, ed. 1996. Alpha1-Antitrypsin Deficiency: Biology, Pathogenesis, Clinical Manifestations, Therapy. Lung Biology in Health and Disease, Vol 88. New York:Marcel Dekker Inc.
Crystal RG, Brantly ML, Hubbard RC, Curiel DT, States DJ, Holmes MD. 1989. The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy. Chest 95:196-208.
de Serres FJ. 2002. Worldwide racial and ethnic distribution of alpha-1-antitrypsin deficiency: details of an analysis of published genetic epidemiological surveys. Chest 122:1818-1829.
de Serres FJ, Blanco I, Bustillo EF. 2003. Genetic epidemiology of alpha-1 antitrypsin deficiency: France, Italy, Portugal, and Spain. Clin Genet 63:490-509.
------. In press. Genetic epidemiology of alpha-1 antitrypsin deficiency: Australia, Canada, New Zealand, and the United States of America. Clin Genet.
Dirksen A, Dijkman JH, Madsen F, Stoel B, Hutchison DCS, Ulrik CS, et al. 1999. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med 160:1468-1472.
Endres W. 1997. Inherited metabolic diseases affecting the carrier. J Inherit Metab Dis 20:9-20.
Fagerhol MK, Cox DW. 1981. The Pi polymorphism: genetic, biochemical, and clinical aspects of human alpha 1-antitrypsin. In: Advances in Genetics, Vol 11. San Diego, CA:Academic Press, 1-62.
Feld RD. 1989. Heterozygosity of alpha 1-antitrypsin: a health risk? Crit Rev Clin Lab Sci 27:461-481.
Fischer S, Struber M, Haverich A. 2002. Current status in lung transplantation: patients, indications, techniques, and outcome. Med Klin 97:137-143.
Gourley MF, Gourley GR, Gilbert EF, Odell GB. 1989. Alpha 1-antitrypsin deficiency and the PiMS phenotype: case report and literature review. J Pediatr Gastroenterol Nutr 8:116-121.
Graziadei IW, Joseph JJ, Wiesner RH, Therneau TM, Batts KP, Porayko MK. 1998. Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency. Hepatology 28:1058-1063.
Hutchison DC. 1983. Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for pi type Z. A survey by the British Thoracic Association. Br J Dis Chest 77:14-27.
Hutchison DC. 1998. Alpha 1-antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z. Respir Med 92:367-377.
Hutchison DC, Cooper D. 2002. Alpha-1-antitrypsin deficiency: smoking, decline in lung function and implications for therapeutic trials. Respir Med 96:872-880.
Hutchison DC, Tobin MJ, Cooper DA, Lowe D. 1986. Longitudinal studies in alpha1-antitrypsin deficiency: a survey by the British Thoracic Society. In: Pulmonary Emphysema and Proteolysis (Taylor JC, Mittman C, eds). Orlando, FL:Academic Press, 7-16.
Hutchison DCS. 1988. Natural history of alpha-1-protease inhibitor deficiency. Am J Med 84(6A):3-12.
Janus ED, Phillips NT, Carrell RW. 1985. Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet 1:152-154.
Kayler LK, Merion RM, Lee S, Sung RS, Punch JD, Rudich SM, et al. 2002. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant 6:295-300.
Kelada SN, Eaton DL, Wang SS, Rothman NR, Khoury MJ. 2003. The role of genetic polymorphisms in environmental health. Environ Health Perspect 111:1055-1064.
Laurell C, Eriksson S. 1963. The electrophoretic alpha-1-globin pattern of serum alpha-1-antitrypsin deficiency. Scand J Clin Invest 15:132-140.
Lieberman J. 2001. Augmentation therapy in alpha(1)-antitrypsin deficiency. Chest 120:687-687.
Lieberman J, Silton RM, Agliozzo CM, McMahon J. 1975. Hepatocellular carcinoma and intermediate alpha 1-antitrypsin deficiency (MZ phenotype). Am J Clin Pathol 64:304-310.
Lieberman J, Winter B, Sastre A. 1986. Alpha 1-antitrypsin pi-types in 965 COPD patients. Chest 89:370-373.
Lima LC, Matte U, Leistner S, Bopp AR, Scholl VC, Giugliani R, et al. 2001. Molecular analysis of the Pi*Z allele in patients with liver disease. Am J Med Genet 104:287-290.
Lolin YI, Ward AM. 1995. Alpha-1-antitrypsin phenotypes and associated disease patterns in neurological patients. Acta Neurol Scand 91:394-398.
Lomas DA. 2000. Loop-sheet polymerization: the mechanism of alpha1-antitrypsin deficiency. Respir Med 94:S3-S6.
Lomas DA, Evans DL, Finch JT, Carrell RW. 1992. The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 357:605-607.
Mahadeva R, Lomas DA. 1998. Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax 53:501-505.
Marcus N, Teckman JH, Perlmutter DH. 1998. Alpha1-antitrypsin deficiency: from genotype to childhood disease. J Pediatr Gastroenterol Nutr 27:65-74.
Mayer AS, Stoller JK, Bucher Bartelson B, James Ruttenber A, Sandhaus RA, Newman LS. 2000. Occupational exposure risks in individuals with Pi*Z 1-antitrypsin deficiency. Am J Respir Crit Care Med 162:553-558.
O'Riordan K, Blei A, Rao MS, Abecassis M. 1997. Alpha 1-antitrypsin deficiency-associated panniculitis: resolution with intravenous alpha 1-antitrypsin administration and liver transplantation. Transplantation 63:480-482.
Parmar JS, Mahadeva R, Reed BJ, Farahi N, Cadwallader KA, Keogan MT, et al. 2002. Polymers of 1-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Respir Cell Mol Biol 26:723-730.
Pierce JA. 1988. Antitrypsin and emphysema. Perspective and prospects. JAMA 259:2890-2895.
Piitulainen E, Eriksson S. 1999. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). Eur Respir J 13:247-251.
Pittschieler K. 1994. Heterozygotes and liver involvement. Acta Paediatr Suppl 393:21-23.
Sandford AJ, Weir TD, Spinelli JJ, Pare PD. 1999. Z and S mutations of the alpha1-antitrypsin gene and the risk of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 20:287-291.
Schievink WI, Katzmann JA, Piepgras DG. 1998. Alpha-1-antitrypsin deficiency in spontaneous intracranial arterial dissections. Cerebrovasc Dis 8:42-44.
Seersholm N, Kok-Jensen A, Dirksen A. 1994. Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases. Thorax 49:695-698.
------. 1995. Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ. Am J Respir Crit Care Med 152:1922-1925.
Seixas S, Garcia O, Trovoada MJ, Santos MT, Amorim A, Rocha J. 2001. Patterns of haplotype diversity within the serpin gene cluster at 14q32.1: insights into the natural history of the alpha1-antitrypsin polymorphism. Hum Genet 108:20-30.
Sigsgaard T, Brandslund I, Omland O, Hjort C, Lund ED, Pedersen OF, et al. 2000. S and Z alpha1-antitrypsin alleles are risk factors for bronchial hyperresponsiveness in young farmers: an example of gene/environment interaction. Eur Respir J 16:50-55.
Spitsyn VA, Nafikova AK, Spitsyna NK, Afanas'eva IS. 2001. Genetic predisposition to alcoholic toxic cirrhosis. Russ J Gen 37:573-580.
Stoller JK, Snider GL, Brantly ML, Fallat RJ, Stockley RA. 2003. Standards for the diagnosis and management of individuals with alpha1-antitrypsin deficiency: a report of the alpha1-antritrypsin deficiency task force. Am J Respir Clin Care Med 168:818-900.
WHO. 1996. AAT Deficiency. Internal Report. Geneva:World Health Organization.
Last Updated: November 13, 2003